Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence
Megan L. Ryan, Daniel E. Falk, Joanne B. Fertig, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 5, pp. 1012-1023
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain
Mayur M. Patel, Bhoomika M. Patel
CNS Drugs (2017) Vol. 31, Iss. 2, pp. 109-133
Closed Access | Times Cited: 362
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
George F. Koob
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 163-201
Open Access | Times Cited: 237
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 112
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Lara A. Ray, Spencer Bujarski, Erica N. Grodin, et al.
The American Journal of Drug and Alcohol Abuse (2018) Vol. 45, Iss. 2, pp. 124-140
Open Access | Times Cited: 114
Oxytocin blocks enhanced motivation for alcohol in alcohol dependence and blocks alcohol effects on GABAergic transmission in the central amygdala
Brendan J. Tunstall, Dean Kirson, Lia J. Zallar, et al.
PLoS Biology (2019) Vol. 17, Iss. 4, pp. e2006421-e2006421
Open Access | Times Cited: 88
Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects
Mariana Rae, Mariana Lemos Duarte, Ivone Gomes, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 8, pp. 1544-1564
Open Access | Times Cited: 56
Medications for alcohol use disorders: An overview
Mohammed Akbar, Mark Egli, Young‐Eun Cho, et al.
Pharmacology & Therapeutics (2017) Vol. 185, pp. 64-85
Open Access | Times Cited: 86
Pharmacotherapy of alcoholism – an update on approved and off-label medications
Michael Soyka, Christian A. Müller
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 12, pp. 1187-1199
Closed Access | Times Cited: 78
Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety
Daniel E. Falk, Megan L. Ryan, Joanne B. Fertig, et al.
Alcoholism Clinical and Experimental Research (2018) Vol. 43, Iss. 1, pp. 158-169
Open Access | Times Cited: 76
Is AD a Stress-Related Disorder? Focus on the HPA Axis and Its Promising Therapeutic Targets
Geoffrey Canet, Célia Hernandez, Charleine Zussy, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 66
The role of oxytocin in alcohol and drug abuse
Courtney King, Anny Gano, Howard C. Becker
Brain Research (2020) Vol. 1736, pp. 146761-146761
Open Access | Times Cited: 60
World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom
Katie Witkiewitz, Nick Heather, Daniel E. Falk, et al.
Addiction (2020) Vol. 115, Iss. 9, pp. 1668-1680
Open Access | Times Cited: 58
Alcohol Use Disorder: The Role of Medication in Recovery
Barbara J. Mason, Charles J. Heyser
Alcohol research (2021) Vol. 41, Iss. 1
Open Access | Times Cited: 47
Consideration of sex and gender differences in addiction medication response
Sherry A. McKee, Aimee L. McRae‐Clark
Biology of Sex Differences (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Theoretical Frameworks and Mechanistic Aspects of Alcohol Addiction: Alcohol Addiction as a Reward Deficit/Stress Surfeit Disorder
George F. Koob, Leandro F. Vendruscolo
Current topics in behavioral neurosciences (2023)
Closed Access | Times Cited: 18
Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial
Katie Witkiewitz, Daniel E. Falk, Raye Z. Litten, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 5, pp. 979-987
Open Access | Times Cited: 53
Addictions Neuroclinical Assessment: A reverse translational approach
Laura E. Kwako, Reza Momenan, Erica N. Grodin, et al.
Neuropharmacology (2017) Vol. 122, pp. 254-264
Open Access | Times Cited: 52
Anticraving therapy for alcohol use disorder: A clinical review
Winston W. Shen
Neuropsychopharmacology Reports (2018) Vol. 38, Iss. 3, pp. 105-116
Open Access | Times Cited: 49
Translational opportunities in animal and human models to study alcohol use disorder
Steven J. Nieto, Erica N. Grodin, Claudia G. Aguirre, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 36
Pharmacological Treatments for Alcohol Use Disorder: Considering the Role of Sex and Gender
Dylan Kirsch, Malia A. Belnap, Elizabeth M. Burnette, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 1, pp. 81-93
Closed Access | Times Cited: 5
Emerging pharmacotherapies for alcohol use disorder
Barbara J. Mason
Neuropharmacology (2017) Vol. 122, pp. 244-253
Open Access | Times Cited: 46
New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies
Kirsten C. Morley, Christina J. Perry, Joshua Watt, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 10, pp. 1291-1303
Closed Access | Times Cited: 32
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
Pascal Valentin Fischler, Michael Soyka, Erich Seifritz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Bidirectional relationship between alcohol intake and sensitivity to social defeat: association with Tacr1 and Avp expression
Britta S. Nelson, Michelle K. Sequeira, Jesse R. Schank
Addiction Biology (2017) Vol. 23, Iss. 1, pp. 142-153
Open Access | Times Cited: 37
Neuropeptide systems and new treatments for nicotine addiction
Adriaan W. Bruijnzeel
Psychopharmacology (2016) Vol. 234, Iss. 9-10, pp. 1419-1437
Open Access | Times Cited: 36
Page 1 - Next Page

Scroll to top